Clinical Trials Browser

Phase 2 × Adenocarcinoma, Follicular × Bortezomib × Clear all

NCT00104871 2018-12-19

Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy

Phase 2 Completed

24 enrolled 6 charts

EndocrineHead & Neck

Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular